1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-

CAS: 164656-23-9

Ref. AN-AG001V0C

Información del producto

• Nombre: 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
• Sinónimos: [u'17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one', u'745, GG', u'Avodart', u'dutasteride', u'GG 745', u'GG-745', u'GG745', u'GI198745', u'Dutasteride', u'164656-23-9', u'Avodart', u'GG-745', u'GG 745', u'GI 198745', u'GI-198745', u'UNII-O0J6XJN02I', u'GI198745', u'O0J6XJN02I', u'CHEMBL1200969', u'Avolve', u'CHEBI:521033', u'Dutasteride, 99%', u'(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide', u'(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide', u'(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(2,5-Bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide', u"alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide", u'C27H30F6N2O2', u'Duagen', u'(1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide', u'Avodart (TN)', u'Avidart', u'Dutasteride (JAN/USAN/INN)', u'Dutasteride [USAN:INN:BAN]', u'NCGC00164571-01', u'GI-198745X', u'AC1OCF98', u'SCHEMBL5903', u'DSSTox_CID_26452', u'DSSTox_RID_81626', u'DSSTox_GSID_46452', u'GTPL7457', u'DTXSID8046452', u'Dutasteride, >=98% (HPLC)', u'AOB5568', u'JWJOTENAMICLJG-QWBYCMEYSA-N', u'BCPP000248', u'BCP02344', u'EX-A1952', u'ZINC3932831', u'Tox21_112199', u'BDBM50340481', u'MFCD00937869', u'NSC740477', u's1202', u'AKOS015920136', u'AKOS015924431', u'BCP9000630', u'CS-1542', u'DB01126', u'GS-3565', u'MCULE-1602474627', u'NSC-740477', u'RL02115', u'N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide', u'BR-72895', u'CC-27419', u'HY-13613', u'SC-08812', u'AB1009276', u'CAS-164656-23-9', u'FT-0080365', u'ST24026289', u'B-2151', u'D03820', u'J10036', u'AB01274774-01', u'AB01274774_02', u'656D239', u'C-23099', u'Q-201052', u'BRD-K30373883-001-02-8', u'Z1563146168', u'Dutasteride, European Pharmacopoeia (EP) Reference Standard', u'Dutasteride, United States Pharmacopeia (USP) Reference Standard', u'(5|A,17|A)-N-{2,5-Bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide', u'Dutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard', u'(1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-3-ene-14-carboxamide', u'(5.alpha.,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide;dutasteride;Avodart;', u'(5alpha,17beta)-N-{2,5-bis(trifluoromethyl)-phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide', u'veltride', u'Dutasteride [USAN]', u'Avidart (TN)', u'Duprost (TN)', u'Dutagen (TN)', u'Avodart, Dutasteride', u'Avolve (TN)', u'Duagen (TN)', u'Dutas (TN)', u'D0A9YA', u'Dutasteride(forbidden drug)', u'Dutasteride [USAN:INN:JAN]', u'GG745', u'2-Hydroxy-4-trifluoromethylpyrimidine', u'745, GG', u'ACN-046785', u'C27-H30-F6-N2-O2', u'CID6918296', u'CS-O-30894', u'C108373', u'D000068538'], (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, (4aR,6aS,7S)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, (4aR,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide, (5Alpha,17Beta)-N-{2,5-Bis(Trifluoromethyl)Phenyl}-3-Oxo-4-Azaandrost-L-Ene-17-Carboxamide, (5α,17β)-N-[(2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxamide, 4-Azaandrost-1-ene-17-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-, (5α,17β)-, Avodart, Avolve, Gg 745, Gi 198745, Veltride
• CAS: 164656-23-9
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 528.5297
• Fórmula: C₂₇H₃₀F₆N₂O₂
• Pureza: 99%
• Color/Forma: Solid
• InChI: InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1
• Clave InChI: JWJOTENAMICLJG-QWBYCMEYSA-N